Jaguar Health, Inc.

Jaguar Health, Inc.

JAGX
Jaguar Health, Inc.US flagNASDAQ Capital Market
1.26
USD
- -
- -
83,966.00Market Cap

Total Valuation

Jaguar Health, Inc. carries a market capitalization of 83,966.00, placing it among publicly traded companies globally. Its enterprise value stands at 35.30M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap83,966.00
Enterprise Value35.30M

Share Statistics

Jaguar Health, Inc. currently has 371,980.00 shares outstanding.

Shares Outstanding371,980.00
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.01, and the price-to-book ratio stands at 0.00.

PE RatioN/A
PS Ratio0.01
PB Ratio0.00
P/TBV Ratio-0.01
P/FCF Ratio-0.05
P/OCF Ratio-0.05

Enterprise Valuation

EV / Sales1.19
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Jaguar Health, Inc. maintains a current ratio of 0.50, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -277.94, indicating conservative leverage, while an interest coverage ratio of -33.37 demonstrates limited ability to service its debt obligations.

Current Ratio0.50
Quick Ratio0.19
Debt / Equity-277.94
Debt / EBITDA-1.88
Interest Coverage-33.37

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-76.77
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)9.57
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.48

Stock Price Statistics

Jaguar Health, Inc.'s stock has declined approximately -98.50622% over the past 52 weeks. The 50-day moving average sits at 2.81, while the 200-day moving average is 27.43.

Beta (5Y)N/A
52-Week Price Change-98.50622%
50-Day Moving Average2.81
200-Day Moving Average27.43
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Jaguar Health, Inc. generated 29.54M in revenue and converted that into -34.12M in net income, yielding earnings per share of -1,196.32. EBITDA reached -23.33M, while operating income came in at -25.50M.

Revenue29.54M
Gross Profit25.13M
Operating Income-25.50M
Pretax Income-34.68M
Net Income-34.12M
EBITDA-23.33M
EBIT-25.50M
Earnings Per Share (EPS)-1,196.32

Balance Sheet

Jaguar Health, Inc. holds 7.28M in cash and equivalents against 43.78M in total debt, resulting in a net debt position of 35.34M. Total book value stands at -391.07M, with working capital of -20.48M providing operational flexibility.

Cash & Cash Equivalents7.28M
Total Debt43.78M
Net Debt35.34M
Equity (Book Value)-391.07M
Book Value Per Share-13,490.93
Working Capital-20.48M

Cash Flow

Jaguar Health, Inc. produced -7.54M in operating cash flow over the past twelve months. After subtracting -41,000.00 in capital expenditures, free cash flow totaled -7.58M - equivalent to -261.60 per share.

Operating Cash Flow-7.54M
Capital Expenditures-41,000.00
Free Cash Flow-7.58M
FCF Per Share-261.60

Margins

Jaguar Health, Inc. operates with a gross margin of 85.05, reflecting its pricing power and cost economics. The operating margin of -86.33 and net profit margin of -115.49 provide insight into operational efficiency.

Gross Margin85.05
Operating Margin-86.33
Pretax Margin-117.38
Profit Margin-115.49
EBITDA Margin-78.96

Dividends & Yields

The company's payout ratio of 31.05 indicates the proportion of earnings distributed to shareholders.

Dividend Per ShareN/A
Dividend YieldN/A
Payout Ratio31.05
Shareholder Yield-3,215.45
FCF Yield-1,995.13

Stock Splits

Jaguar Health, Inc.'s most recent stock split took place on April 30, 2026 with a 35:1 split ratio.

Last Split Date4/30/2026
Split Ratio35:1

Scores

Jaguar Health, Inc. posts an Altman Z-Score of -28.64, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-28.64